JAVOLA Trademark

Trademark Overview

On Wednesday, December 24, 2008, a trademark application was filed for JAVOLA with the United States Patent and Trademark Office. The USPTO has given the JAVOLA trademark a serial number of 77639606. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2013. This trademark is owned by Glaxo Group Limited. The JAVOLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
javola

General Information

Serial Number77639606
Word MarkJAVOLA
Filing DateWednesday, December 24, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "JAVOLA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 29, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, October 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 14, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2013EXTENSION 3 GRANTED
Wednesday, February 27, 2013EXTENSION 3 FILED
Wednesday, February 27, 2013TEAS EXTENSION RECEIVED
Thursday, September 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 12, 2012EXTENSION 2 GRANTED
Thursday, September 6, 2012EXTENSION 2 FILED
Thursday, September 6, 2012TEAS EXTENSION RECEIVED
Thursday, March 29, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 28, 2012EXTENSION 1 GRANTED
Monday, March 5, 2012EXTENSION 1 FILED
Friday, March 23, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 5, 2012TEAS EXTENSION RECEIVED
Tuesday, September 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 13, 2011ASSIGNED TO EXAMINER
Tuesday, May 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 16, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 27, 2011LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, October 14, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 5, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 30, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 30, 2009LETTER OF SUSPENSION E-MAILED
Wednesday, September 30, 2009SUSPENSION LETTER WRITTEN
Thursday, September 3, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2009ASSIGNED TO LIE
Friday, August 28, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 14, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 14, 2009NON-FINAL ACTION E-MAILED
Saturday, March 14, 2009NON-FINAL ACTION WRITTEN
Saturday, March 14, 2009ASSIGNED TO EXAMINER
Monday, December 29, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

javola pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic